Perioperative chemotherapy with or without bevacizumab in patients with metastatic colorectal cancer undergoing liver resection. [electronic resource]
Producer: 20130822Description: 15-22 p. digitalISSN:- 1938-0674
- Adult
- Aged
- Antibodies, Monoclonal, Humanized -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Bevacizumab
- Camptothecin -- administration & dosage
- Capecitabine
- Colorectal Neoplasms -- drug therapy
- Combined Modality Therapy
- Deoxycytidine -- administration & dosage
- Female
- Fluorouracil -- administration & dosage
- Follow-Up Studies
- Humans
- Irinotecan
- Liver Neoplasms -- drug therapy
- Male
- Middle Aged
- Neoplasm Staging
- Organoplatinum Compounds -- administration & dosage
- Oxaliplatin
- Perioperative Care
- Postoperative Complications
- Prognosis
- Retrospective Studies
- Survival Rate
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.